Coronary Artery Disease Clinical Trials in Royal Oak, Michigan

4 studies are recruiting for coronary artery disease in Royal Oak, Michigan right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.

    This is a two-part study, comprised of an initial open-label run-in phase (Part 1) in a subset of 3 subjects to provide first data regarding safety, and feasibility of the percutaneous endovascular catheter-facilitated intramyocardial delivery of XC001 in patients with RA due to obstructive CAD. Pa…

    Stage
    Phase 2
    Ages
    18 to 85
    Site
    Corewell Health Research Institute, Royal Oak, Michigan
    Locations
    14 in total
    Run by
    XyloCor Therapeutics, Inc.

    See if you can join NCT07048808 on ClinicalTrials.gov

  2. Virtue® SAB in the Treatment of Coronary ISR Trial

    A prospective, multi-center, single-blind, randomized (1:1), non-inferiority study comparing clinical outcomes of the Virtue® Sirolimus AngioInfusion™ Balloon (SAB) to the AGENT™ Paclitaxel Drug-Coated Balloon (DCB) in the treatment of coronary artery in-stent restenosis (ISR).

    Stage
    Not phased
    Ages
    18 and older
    Site
    Corewell Health William Beaumont University Hospital, Royal Oak, Michigan
    Locations
    15 in total
    Run by
    Orchestra BioMed, Inc

    See if you can join NCT07045194 on ClinicalTrials.gov

  3. Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

    The central hypothesis of ROMA:Women is that the use of multiple arterial grafting (MAG) will improve clinical outcomes and quality of life (QOL) compared to single arterial grafting (SAG). The specific aims of ROMA:Women are: Aim 1: Determine the impact of MAG vs SAG on major adverse cardiac and c…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Corewell Health William Beaumont University Hospital, Royal Oak, Michigan
    Locations
    146 in total
    Run by
    Weill Medical College of Cornell University

    See if you can join NCT04124120 on ClinicalTrials.gov

  4. Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

    Patients undergoing transcatheter aortic valve replacement (TAVR) often have concomitant coronary artery disease (CAD) which may adversely affect prognosis. There is uncertainty about the benefits and the optimal timing of revascularization for such patients. There is currently clinical equipoise r…

    Stage
    Not phased
    Ages
    Any age
    Site
    William Beaumont Hospital, Royal Oak, Michigan
    Locations
    72 in total
    Run by
    University of British Columbia

    See if you can join NCT04634240 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.